SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-136281
Filing Date
2020-12-16
Accepted
2020-12-16 16:11:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2038389-2_424b5.htm 424B5 1044871
2 GRAPHIC lg_tgtherapeutics-4clr.jpg GRAPHIC 22193
  Complete submission text file 0001104659-20-136281.txt   1076876
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233636 | Film No.: 201392546
SIC: 2834 Pharmaceutical Preparations